AI assistant
Sending…
COLGATE PALMOLIVE CO — Director's Dealing 2022
Aug 17, 2022
29956_dirs_2022-08-17_a630c4dd-9b98-4636-b0c8-0b8eac0a6d6f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: COLGATE PALMOLIVE CO (CL)
CIK: 0000021665
Period of Report: 2022-08-16
Reporting Person: Tsourapas Panagiotis (Grp Pres, Eur& Developing Mkts)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-16 | Common Stock | M | 35976.0000 | $72.9900 | Acquired | 42795.0000 | Direct |
| 2022-08-16 | Common Stock | F | 34007.0000 | $82.1800 | Disposed | 8788.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-16 | Stock Option (Right to Buy) | $72.9900 | M | 35976.0000 | Disposed | 2022-09-08 | Common Stock (35976.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 3394.0000 | Indirect |
| Common Stock | 3211.0000 | Indirect |
| Common Stock | 51090.0000 | Indirect |
Footnotes
F1: Exercise of stock options awarded under the issuer's incentive compensation plan.
F2: The exercise price of the options and related tax withholding requirement were satisfied by the Company's withholding shares otherwise deliverable upon exercise of the options.
F3: This amount includes 8,528 shares that were previously reported as directly beneficially owned.
F4: Option became exercisable in one-third increments beginning on the first anniversary of the September 8, 2016 grant date.
More from COLGATE PALMOLIVE CO
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 1
Regulatory Filings
2026
May 1
Major Shareholding Notification
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 16
Regulatory Filings
2026
Apr 9
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25